APA

Kapoor P., Fonseca R., Rajkumar S. V., Sinha S., Gertz M. A., Stewart A. K., Bergsagel P. L., Lacy M. Q., Dingli D. D., Ketterling R. P., Buadi F., Kyle R. A., Witzig T. E., Greipp P. R., Dispenzieri A. & Kumar S. (20100618). Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapie. : Mayo Clinic proceedings.

Chicago

Kapoor Prashant, Fonseca Rafael, Rajkumar S Vincent, Sinha Shirshendu, Gertz Morie A, Stewart A Keith, Bergsagel P Leif, Lacy Martha Q, Dingli David D, Ketterling Rhett P, Buadi Francis, Kyle Robert A, Witzig Thomas E, Greipp Philip R, Dispenzieri Angela and Kumar Shaji. 20100618. Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapie. : Mayo Clinic proceedings.

Harvard

Kapoor P., Fonseca R., Rajkumar S. V., Sinha S., Gertz M. A., Stewart A. K., Bergsagel P. L., Lacy M. Q., Dingli D. D., Ketterling R. P., Buadi F., Kyle R. A., Witzig T. E., Greipp P. R., Dispenzieri A. and Kumar S. (20100618). Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapie. : Mayo Clinic proceedings.

MLA

Kapoor Prashant, Fonseca Rafael, Rajkumar S Vincent, Sinha Shirshendu, Gertz Morie A, Stewart A Keith, Bergsagel P Leif, Lacy Martha Q, Dingli David D, Ketterling Rhett P, Buadi Francis, Kyle Robert A, Witzig Thomas E, Greipp Philip R, Dispenzieri Angela and Kumar Shaji. Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapie. : Mayo Clinic proceedings. 20100618.